These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 6610749
1. HLA antigens and drug toxicity in rheumatoid arthritis. Ford PM. J Rheumatol; 1984 Jun; 11(3):259-61. PubMed ID: 6610749 [No Abstract] [Full Text] [Related]
4. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis. Scherak O, Smolen JS, Mayr WR, Mayrhofer F, Kolarz G, Thumb NJ. J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866 [Abstract] [Full Text] [Related]
5. HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. Dahlqvist SR, Ström H, Bjelle A, Möller E. Clin Rheumatol; 1985 Mar; 4(1):55-61. PubMed ID: 3157529 [Abstract] [Full Text] [Related]
7. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine. Stockman A, Zilko PJ, Major GA, Tait BD, Property DN, Mathews JD, Hannah MC, McCluskey J, Muirden KD. J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889 [Abstract] [Full Text] [Related]
8. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. Wooley PH, Griffin J, Panayi GS, Batchelor JR, Welsh KI, Gibson TJ. N Engl J Med; 1980 Aug 07; 303(6):300-2. PubMed ID: 6770269 [Abstract] [Full Text] [Related]
11. [Rheumatoid arthritis. Requirements of a correct diagnostic determination for a more personalized therapy]. Ferraccioli GF, Ambanelli U. Recenti Prog Med; 1984 Oct 07; 75(10):883-8. PubMed ID: 6334875 [No Abstract] [Full Text] [Related]
12. Membranous glomerulonephritis in rheumatoid arthritis not related to gold or D-penicillamine therapy: a report of four cases and review of the literature. Honkanen E, Törnroth T, Pettersson E, Skrifvars B. Clin Nephrol; 1987 Feb 07; 27(2):87-93. PubMed ID: 3829481 [Abstract] [Full Text] [Related]
13. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens. Moens HJ, Ament BJ, Feltkamp BW, van der Korst JK. J Rheumatol; 1987 Dec 07; 14(6):1115-9. PubMed ID: 3437418 [Abstract] [Full Text] [Related]
14. D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3. Emery P, Panayi GS, Huston G, Welsh KI, Mitchell SC, Shah RR, Idle JR, Smith RL, Waring RH. J Rheumatol; 1984 Oct 07; 11(5):626-32. PubMed ID: 6334741 [Abstract] [Full Text] [Related]
15. The HLA system in rheumatoid arthritis. Panayi GS. Eur J Rheumatol Inflamm; 1982 Oct 07; 5(4):423-4. PubMed ID: 6983961 [No Abstract] [Full Text] [Related]
16. HLA-DR4 antigen and IgM rheumatoid factors. Queirós MV, Sancho MR, Caetano JM. J Rheumatol; 1982 Oct 07; 9(3):370-3. PubMed ID: 6981703 [Abstract] [Full Text] [Related]